Clinical trial

A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes

NCT03224234

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-11-29

PhaseNA

Study timeline

Study start (actual)2017-11-29Date precision: day

Registry last updated2021-01-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Interventions

Insulclock with feedbackDEVICE

Insulclock without feedbackDEVICE

Sponsors & collaborators

Emory Universitylead sponsor

Insulcloud S.L.collaborator

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03224234 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.